vs

Side-by-side financial comparison of Black Stone Minerals, L.P. (BSM) and MEDIFAST INC (MED). Click either name above to swap in a different company.

Black Stone Minerals, L.P. is the larger business by last-quarter revenue ($95.2M vs $75.1M, roughly 1.3× MEDIFAST INC). On growth, Black Stone Minerals, L.P. posted the faster year-over-year revenue change (-8.7% vs -36.9%). Over the past eight quarters, Black Stone Minerals, L.P.'s revenue compounded faster (-9.7% CAGR vs -34.4%).

Black Stone Minerals, L.P., or Black Stone Minerals, is a Houston, Texas-based oil and natural gas corporation.

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

BSM vs MED — Head-to-Head

Bigger by revenue
BSM
BSM
1.3× larger
BSM
$95.2M
$75.1M
MED
Growing faster (revenue YoY)
BSM
BSM
+28.2% gap
BSM
-8.7%
-36.9%
MED
Faster 2-yr revenue CAGR
BSM
BSM
Annualised
BSM
-9.7%
-34.4%
MED

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BSM
BSM
MED
MED
Revenue
$95.2M
$75.1M
Net Profit
$72.2M
Gross Margin
69.4%
Operating Margin
78.6%
-10.4%
Net Margin
75.9%
Revenue YoY
-8.7%
-36.9%
Net Profit YoY
55.8%
EPS (diluted)
$-1.64

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BSM
BSM
MED
MED
Q4 25
$95.2M
$75.1M
Q3 25
$105.2M
$89.4M
Q2 25
$106.7M
$105.6M
Q1 25
$115.3M
$115.7M
Q4 24
$104.3M
$119.0M
Q3 24
$103.2M
$140.2M
Q2 24
$115.2M
$168.6M
Q1 24
$116.8M
$174.7M
Net Profit
BSM
BSM
MED
MED
Q4 25
$72.2M
Q3 25
$91.7M
$-2.3M
Q2 25
$120.0M
$2.5M
Q1 25
$15.9M
$-772.0K
Q4 24
$46.3M
Q3 24
$92.7M
$1.1M
Q2 24
$68.3M
$-8.2M
Q1 24
$63.9M
$8.3M
Gross Margin
BSM
BSM
MED
MED
Q4 25
69.4%
Q3 25
69.5%
Q2 25
72.6%
Q1 25
72.8%
Q4 24
74.1%
Q3 24
75.4%
Q2 24
73.2%
Q1 24
72.8%
Operating Margin
BSM
BSM
MED
MED
Q4 25
78.6%
-10.4%
Q3 25
89.5%
-4.6%
Q2 25
-1.0%
Q1 25
14.9%
-1.1%
Q4 24
45.6%
0.6%
Q3 24
90.2%
1.5%
Q2 24
59.5%
-4.7%
Q1 24
54.8%
4.5%
Net Margin
BSM
BSM
MED
MED
Q4 25
75.9%
Q3 25
87.2%
-2.5%
Q2 25
112.5%
2.3%
Q1 25
13.8%
-0.7%
Q4 24
44.4%
Q3 24
89.9%
0.8%
Q2 24
59.3%
-4.8%
Q1 24
54.7%
4.8%
EPS (diluted)
BSM
BSM
MED
MED
Q4 25
$-1.64
Q3 25
$-0.21
Q2 25
$0.22
Q1 25
$-0.07
Q4 24
$0.08
Q3 24
$0.10
Q2 24
$-0.75
Q1 24
$0.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BSM
BSM
MED
MED
Cash + ST InvestmentsLiquidity on hand
$1.5M
$167.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$198.9M
Total Assets
$1.3B
$248.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BSM
BSM
MED
MED
Q4 25
$1.5M
$167.3M
Q3 25
$2.9M
$173.5M
Q2 25
$2.5M
$162.7M
Q1 25
$2.4M
$164.6M
Q4 24
$2.5M
$162.3M
Q3 24
$21.0M
$170.0M
Q2 24
$26.7M
$163.5M
Q1 24
$40.5M
$156.4M
Stockholders' Equity
BSM
BSM
MED
MED
Q4 25
$198.9M
Q3 25
$214.7M
Q2 25
$216.0M
Q1 25
$211.0M
Q4 24
$210.1M
Q3 24
$207.3M
Q2 24
$205.3M
Q1 24
$211.0M
Total Assets
BSM
BSM
MED
MED
Q4 25
$1.3B
$248.0M
Q3 25
$1.3B
$268.2M
Q2 25
$1.3B
$269.3M
Q1 25
$1.2B
$280.0M
Q4 24
$1.2B
$284.2M
Q3 24
$1.2B
$291.2M
Q2 24
$1.2B
$293.5M
Q1 24
$1.2B
$302.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BSM
BSM
MED
MED
Operating Cash FlowLast quarter
$65.1M
$-5.3M
Free Cash FlowOCF − Capex
$-6.6M
FCF MarginFCF / Revenue
-8.8%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
0.90×
TTM Free Cash FlowTrailing 4 quarters
$1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BSM
BSM
MED
MED
Q4 25
$65.1M
$-5.3M
Q3 25
$99.8M
$12.1M
Q2 25
$80.5M
$-3.4M
Q1 25
$64.8M
$3.4M
Q4 24
$91.0M
$-4.9M
Q3 24
$93.2M
$9.1M
Q2 24
$100.4M
$13.1M
Q1 24
$104.5M
$7.3M
Free Cash Flow
BSM
BSM
MED
MED
Q4 25
$-6.6M
Q3 25
$10.8M
Q2 25
$-4.8M
Q1 25
$1.9M
Q4 24
$-7.2M
Q3 24
$7.7M
Q2 24
$11.1M
Q1 24
$5.4M
FCF Margin
BSM
BSM
MED
MED
Q4 25
-8.8%
Q3 25
12.0%
Q2 25
-4.5%
Q1 25
1.6%
Q4 24
-6.1%
Q3 24
5.5%
Q2 24
6.6%
Q1 24
3.1%
Capex Intensity
BSM
BSM
MED
MED
Q4 25
1.8%
Q3 25
1.5%
Q2 25
1.3%
Q1 25
1.3%
Q4 24
1.9%
Q3 24
1.0%
Q2 24
1.1%
Q1 24
1.1%
Cash Conversion
BSM
BSM
MED
MED
Q4 25
0.90×
Q3 25
1.09×
Q2 25
0.67×
-1.36×
Q1 25
4.07×
Q4 24
1.96×
Q3 24
1.01×
8.04×
Q2 24
1.47×
Q1 24
1.63×
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BSM
BSM

Oil Reserves$46.4M49%
Natural Gas Reserves$44.1M46%
Real Estate$4.7M5%

MED
MED

Segment breakdown not available.

Related Comparisons